CIRCULATING TUMOR CELLS (CTC) FOR PROSTATE CANCER

This assay is useful as an aid in monitoring patients with metastatic prostate cancer. The self search system identifies and enumerates the number of circulating tumor cells in blood. This number correlates well with progression and overall survival in patients with metastatic prostate cancer. Patients on Doxorubicin (Adriamycin) must give a gap of minimum 7 days prior to blood sampling.

  • Test Type:
  • Pre-test Information:
    Patients on Adriamycin must wait a minimum of 7 days post administration before blood is drawn for this test.
  • Report Delivery:
    Contact National Reference Lab, New Delhi
  • Components:
    0

Sample Report

ctc circulating tumor cells prostate cancer in other Cities